Stay updated on Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial

Sign up to get notified when there's something new on the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page adds a footer revision note 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' link and the previous revision note 'Revision: v3.3.2' were removed.
    Difference
    0.1%
    Check dated 2025-12-24T16:33:12.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    - Results Submitted added to the study record, and the revision updated to v3.3.2, replacing No Results Posted and v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T14:42:07.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The notification about government funding and operating status was removed from the page; this does not affect the study details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:29:30.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    No significant changes were detected on the page; the content and layout remain as before. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:54:11.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Update: new operating-status notice and v3.2.0 release; removes the old v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-06T07:57:54.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Page now updates to v3.1.0 and removes the Head and neck squamous cell carcinoma resource under Genetic and Rare Diseases Information Center resources; no other major content changes.
    Difference
    0.5%
    Check dated 2025-09-29T04:30:52.000Z thumbnail image

Stay in the know with updates to Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page.